Mar. 12, 2019 |
|
Dec. 31, 2020 |
|
jRCTs031180234 |
Comparative test on the effectiveness and safety of B blocker topical treatment with different concentrations of active ingredients against superficial infantile hemangioma (Comparative test on the effectiveness and safety of B blocker topical treatment with different concentrations of active ingredients against superficial infantile hemangioma) |
|
Comparative test of B blocker topical treatment with different concentrations of active ingredients against infantile hemangioma (Comparative test of B blocker topical treatment with different concentrations of active ingredients against infantile hemangioma) |
May. 31, 2019 |
|
19 |
|
Superficial and mixed type infantile hemangioma. More than 50% of tumor is present on the skin surface in lesion 0% group; total 7 cases (1 male and 6 females), age range 2 1% group; total 6 cases (1 male and 5 females), age range 2-5 5% group; total 6 cases (no male and 6 females), age range 2-8 |
|
Data fixation, Per protocol set 0% group; total 7 cases (1 male and 6 females), age range 2 1% group; total 4 cases (1 male and 3 females), age range 2-5 5% group; total 4 cases (no male and 4 females), age range 2-8 |
|
There were 4 cases of pruritus in the application area. There was one case of onset asthma, but the causal relationship with B-blocker application was unknown. In addition, influenza and infectious gastroenteric were observed. |
|
In the PPS, the main endpoint, the rate of change in the average number of brightness in the area where the tumor exists after 6 months, three groups are same, i.e., 0.9. There was no difference. A difference in the average number of brightness in the area where the tumor exists after 6 months was examined. A tendency was observed that the number of brightness decreased. |
|
The topical propranolol gel did not diminish the redness of IH after the proliferative phase in Japanese pediatric patients. However, our results imply that the topical propranolol gel has a limited effect on the satisfaction of parents and a favorable safety profile. |
|
Dec. 31, 2020 |
|
Jan. 01, 2022 |
|
https://www.jstage.jst.go.jp/article/bpb/45/1/45_b2100500/_article |
No |
|
No plan |
|
https://jrct.niph.go.jp/latest-detail/jRCTs031180234 |
Mitsukawa Nobuyuki |
||
Chiba University Hospital |
||
Inohana1-8-1 Chuo-ku Chiba Chiba, Japan |
||
+81-43-222-7171 |
||
nmitsu@faculty.chiba-u.jp |
||
Rikihisa Naoaki |
||
Chiba University Hospital |
||
Inohana1-8-1 Chuo-ku Chiba Chiba, Japan |
||
+81-43-222-7171 |
||
rikihisa@faculty.chiba-u.jp |
Complete |
Oct. 01, 2015 |
||
Oct. 09, 2015 | ||
19 | ||
Interventional |
||
randomized controlled trial |
||
double blind |
||
dose comparison control |
||
parallel assignment |
||
treatment purpose |
||
Superficial and mixed type infantile hemangioma. |
||
1. Patients with asthma. Cases with Asthma suspected |
||
2age old over | ||
15age old under | ||
Both |
||
Infantile hemangioma |
||
Apply 0% or 1% or 5% propranolol ointment twice daily for 6 months. Apply an ointment with one little finger head size per 200 cm2 over the entire tumor over 5 seconds. |
||
Infantile hemangioma, Strawberry mark |
||
021 |
||
Change rate of tumor color tone |
||
Tumor area (long axis by short axis). |
Chiba rosai hospital | |
Not applicable |
Chiba University Hospital Certified Clinical Research Review Board | |
Inohana 1-8-1 Chuo-ku Chiba, Chiba | |
+81-43-226-2616 |
|
prc-jim@chiba-u.jp | |
Approval | |
Feb. 27, 2019 |
UMIN000012123 | |
University hospital Medical Information Network - Clinical Trials Registry |
none |